Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Opioid-related disorders
MeSH D009293 - opioid-related disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000079524:
Narcotic-related disorders
0 Companies
0 Drugs
Success rate
D009293:
Opioid-related disorders
71 Companies
13 Drugs
$
Success rate
D000074607:
Opium dependence
0 Companies
0 Drugs
Success rate
D000083682:
Opiate overdose
0 Companies
0 Drugs
Success rate
D006556:
Heroin dependence
29 Companies
3 Drugs
$
Success rate
D009021:
Morphine dependence
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
69
%
33/48
Phase 2
45
%
30/66
Phase 3
60
%
24/40
Approved:
10
Overall Success rate:
19%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Buprenorphine
,
Buprenorphine hydrochloride
AstraZeneca
Naloxone
,
Aspartame
,
Nktr118
,
Cam2038
,
AZD4041
Bausch Health Companies
Methylnaltrexone
,
Methylnaltrexone bromide
1
2
3
4
5
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use